Every Form 4 that RH (RH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RH filings page.
RH director Mark S. Demilio reported that The Mark S. Demilio Revocable Trust sold 1,000 RH common shares on September 22, 2026, at $132 per share. The footnote states that the shares had previously been owned directly by Demilio and were contributed to the trust. A separate holding entry reports 11,593 common shares held directly by Demilio as of September 22, 2026.
RH director Mark S. Demilio reported open-market sales totaling 2,445 shares of common stock on July 10, 2026. The sales were executed in two transactions at prices of $169.00 and $167.9466 per share, with one transaction carried out through multiple trades between $167.61 and $168.01 using a weighted average price. Following these transactions, Demilio continues to hold RH stock both directly and indirectly through trusts, including 12,593 shares held directly, and 2,295 shares that were previously owned directly have been contributed to The Mark S. Demilio Revocable Trust.
RH Chairman and CEO Gary G. Friedman reported open‑market sales of RH common stock. Over July 6–8, 2026, he sold a total of 125,000 shares across 11 transactions. Reported sale prices ranged from about $154.71 to $171.11, with each line item reflecting a weighted average sale price executed in multiple trades.
RH director Carlos Alberini reported new open-market purchases of RH common stock made through a family trust. On 2026-06-29, the Carlos and Andrea Alberini Trust bought 5,586 shares at a weighted average price of $161.3407 per share and 5,502 shares at a weighted average price of $160.5823 per share. The trust also purchased 300 shares at a weighted average price of $158.4980 per share, with each transaction executed in multiple trades within disclosed price ranges.
After these transactions, Alberini holds 3,174 RH shares directly and 32,190 shares indirectly through the Carlos and Andrea Alberini Trust, which includes 20,802 shares previously owned directly and contributed to the trust.
ALBERINI CARLOS reported acquisition or exercise transactions in this Form 4 filing.
RH director Carlos Alberini received an award of 843 shares of common stock as compensation. The grant is structured as restricted stock, which will vest in full on the one-year anniversary of the grant date. After this award, Alberini directly holds a total of 23,976 RH shares.
SCHLESINGER LEONARD A reported acquisition or exercise transactions in this Form 4 filing.
RH director Leonard A. Schlesinger received a grant of 843 shares of RH common stock as equity compensation. The award is in the form of restricted stock that will vest in full on the one-year anniversary of the grant date. Following this grant, he directly holds 16,134 RH shares.
Mitic Kathleen C. reported acquisition or exercise transactions in this Form 4 filing.
RH director Kathleen C. Mitic received a grant of 843 shares of RH common stock as a stock award. The shares were granted at no cash cost per share and are structured as restricted stock that will vest in full on the one-year anniversary of the grant date. Following this award, she holds a total of 12,899 RH common shares directly, indicating the transaction is a routine compensation-related equity grant rather than an open-market purchase or sale.
Krane Hilary K reported acquisition or exercise transactions in this Form 4 filing.
RH director Hilary K. Krane received a grant of 843 shares of RH common stock as a restricted stock award. The award was granted at no cash cost per share and will vest in full on the one-year anniversary of the grant date. Following this grant, Krane directly holds 8,598 shares of RH common stock.
Belling Keith reported acquisition or exercise transactions in this Form 4 filing.
RH director Keith Belling received a grant of 843 shares of RH common stock as a restricted stock award. The shares were awarded at no cash cost per share and are scheduled to vest in full on the one-year anniversary of the grant date. Following this compensation-related award, Belling directly holds 6,483 shares of RH common stock. This filing reflects an equity grant rather than an open-market purchase or sale.
RH director Ali Rowghani reported a compensation-related stock grant and updated holdings. He received an award of 843 shares of RH common stock as restricted stock at a stated price of $0.0000 per share. The award will vest in full on the one-year anniversary of the grant date.
Following this grant, Rowghani holds 2,060 RH common shares directly and 9,525 shares indirectly through the Rowghani Keshavarz Living Trust, where he is a beneficiary and co-trustee. The filing reflects an acquisition of shares through an equity award, not an open-market purchase or sale.
RH director Mark S. Demilio reported a mix of stock awards and sales involving company shares. He received an award of 843 shares of restricted stock at no cost, which will vest in full on the one-year anniversary of the grant.
Family trusts associated with Demilio sold RH common stock in open-market transactions, including 3,102 shares at a weighted average price of about $144.00 per share and 2,202 shares at $150.00 per share. After the award, the filing shows Demilio holding 14,888 shares directly, with additional indirect holdings reported through family trusts.
DEMILIO MARK S reported acquisition or exercise transactions in this Form 4 filing.
RH director Mark S. Demilio reported receiving a grant of 13,000 shares of RH common stock as a restricted stock award. The award vests in eight equal quarterly installments over two years, subject to his continuing service on the Board’s Real Estate Committee, and is scheduled to be fully vested as of January 1, 2028.
Following the award, Demilio holds 18,170 shares directly. In addition, 27,009 shares are held by The Mark S. Demilio Revocable Trust, which includes 7,047 shares previously owned directly and later contributed, and 19,425 shares are held by The Theresa E. Demilio 2012 Family Trust, where he is a beneficiary and co-trustee.
RH officer Lisa Chi received a stock option grant for 30,000 shares of common stock. The option has an exercise price of $130.7200 per share and expires on April 13, 2036. Following this grant, she holds 30,000 derivative securities.
The award vests over seven years, subject to continuous service: 10% on each of the first three anniversaries of the grant date, 15% on each of the fourth and fifth anniversaries, and 20% on each of the sixth and seventh anniversaries.
RH reported that director and officer Chaya Eri received a grant of stock options covering 40,000 shares of RH common stock. The options have an exercise price of $130.72 per share and expire on April 13, 2036.
The award vests over seven years, subject to continuous service: 10% on each of the first three anniversaries of the grant date, 15% on each of the fourth and fifth anniversaries, and 20% on each of the sixth and seventh anniversaries. Following this grant, Eri holds stock options on 40,000 shares directly.
RH reported that Chief Accounting Officer Christina Hargarten received a grant of stock options covering 7,500 shares of RH common stock. The options have an exercise price of $130.72 per share and expire on April 13, 2036.
According to the award terms, the options vest over seven years, subject to continuous service. 10% vest on each of the first three anniversaries of the grant date, 15% on each of the fourth and fifth anniversaries, and 20% on each of the sixth and seventh anniversaries.
RH reported that its Chief Financial Officer, Jack M. Preston, received a grant of stock options covering 25,000 shares of common stock. The options have an exercise price of $130.72 per share and expire on April 13, 2036, providing long-term, performance-linked compensation.
According to the disclosure, the award vests over seven years, with 10% of the options vesting on each of the first three anniversaries of the grant date, 15% on each of the fourth and fifth anniversaries, and 20% on each of the sixth and seventh anniversaries, subject to continuous service.
RH director and officer Chaya Eri exercised stock options and increased indirect share holdings. Eri exercised a stock option to acquire 25,000 shares of RH common stock at 39.42 per share, fully using this option award. The acquired shares were then transferred to the Chaya-Smith Revocable Trust, which now holds 48,643 shares indirectly on Eri’s behalf. No shares were sold in this filing, and no derivative position remains from this particular option grant.
RH director and officer Chaya Eri received a grant of stock options covering 1,000 shares of RH common stock. The options have an exercise price of $113.46 per share and expire on April 4, 2036.
According to the vesting terms, one-seventh of the total options vests on each anniversary of the grant date, so the award becomes fully vested after seven years, subject to continuous service. Following this grant, Eri holds 1,000 derivative securities linked to RH common stock.
RH chief accounting officer Christina Hargarten exercised restricted stock units and received 1,125 shares of common stock on March 30, 2026. The RSUs converted at a price of $0.00 per share, reflecting equity compensation rather than an open-market purchase.
After the transaction, she directly held 2,359 shares of RH common stock and 4,125 restricted stock units. The footnotes explain that these RSUs come from a 7,500-unit grant dated January 31, 2022, with portions vesting annually from March 30, 2023 through March 30, 2029, subject to continuous service.
RH director and officer Eri Chaya exercised stock options for 11,000 shares of common stock at an exercise price of $39.42 per share and then sold the same 11,000 shares in a series of open-market transactions.
The sales, made on March 31, 2026 at weighted average prices ranging from about $135.27 to $140.02 per share, were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on October 7, 2024. Following these transactions, Chaya reported no directly held shares, and 23,643 shares held indirectly by the Chaya-Smith Revocable Trust.
RH director and officer Chaya Eri reported an option exercise and related share sales. Eri exercised 7,000 stock options at an exercise price of $39.42 per share, receiving 7,000 shares of common stock. On the same day, she sold 7,000 common shares in multiple open-market transactions at weighted average prices between roughly $127.96 and $130.74 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on October 7, 2024. Following these transactions, no direct common stock holdings are reported, while 23,643 shares are reported as held indirectly by the Chaya-Smith Revocable Trust.
RH director and officer Chaya Eri exercised stock options for 7,000 shares of common stock at an exercise price of $39.4200 per share, then sold all 7,000 shares in open-market transactions on March 17, 2026.
The sales were executed in three tranches: 2,700 shares at a weighted average price of $134.5044, 3,292 shares at $135.7018, and 1,008 shares at $136.3972, under a Rule 10b5-1 trading plan adopted on October 7, 2024. After these transactions, Eri holds 43,000 stock options directly and 23,643 shares of common stock indirectly through the Chaya-Smith Revocable Trust.
RH reported an insider equity vesting for senior executive Lisa Chi. On January 31, 2026, 6,000 restricted stock units (RSUs) vested and were converted into 6,000 shares of RH common stock at an exercise price of $0, all held directly.
These RSUs are part of a 20,000-unit award granted on May 30, 2025. The award vests over three years: 6,000 units vested on January 31, 2026, and 7,000 units are scheduled to vest on January 31, 2027 and January 31, 2028, subject to continuous service. After this transaction, Chi directly holds 14,000 RSUs and 6,000 shares of common stock.
Trusts associated with RH director Mark S. Demilio reported sales of RH common stock. On January 13, 2026, The Mark S. Demilio Revocable Trust sold 2,000 RH shares at $220.1001 per share. On January 14, 2026, a trust reported as held "By Trust" sold an additional 2,254 shares at $220 per share.
After these transactions, one trust held 22,216 shares and then 19,962 shares following the later sale, another trust, The Theresa E. Demilio 2012 Family Trust, held 19,425 shares, and Mark S. Demilio also held 12,217 shares directly. The filing identifies Demilio as a director of RH and reports these positions as indirect or direct beneficial ownership through the respective trusts and personal holdings.
RH director Mark S. Demilio, through affiliated trusts, reported open-market sales of RH common stock. On 12/30/2025, a trust sold 500 shares at a price of $184 per share, and on 12/31/2025, a trust sold 400 shares at a weighted average price of $180.1692 per share. After these transactions, one trust held 24,116 shares, another trust held 19,425 shares, and Demilio also held 12,717 shares directly. The filing notes that the 12/31/2025 sale was executed in multiple trades within a specified price range, with detailed trade data available upon request.